Results 1 to 10 of about 388,469 (218)
How sexuality is affected and managed in patients under antipsychotic drugs
European Psychiatry, 2023 Introduction Sexual dysfunction (SD) is a prevalent side effect of antipsychotic drugs (AP), and it impairs patients’ quality of life. Because of the distress caused by it, it should be borne in mind when prescribed since it is responsible for treatment
F. Ribeirinho Soares +8 more
doaj +1 more source
BIG LITTLE THIEFS - Kleptomania Treatment
European Psychiatry, 2022 Introduction Kleptomania is characterized by recurrent failure to resist the impulse to steal items of little value despite the ego-dystonic impulse and awareness of the wrongfulness of the act. Its prevalence is considered to be 0.6–0.8% in the general
S. Mouta +5 more
doaj +1 more source
Increased risk of health professionals to feel traumatized during the COVID-19 pandemic
Scientific Reports, 2021 Health professionals may be a vulnerable group to posttraumatic stress symptoms (PTSS) during the Coronavirus disease 2019 (COVID-19) pandemic. To investigate how health professionals who experienced a traumatic event are expressing PTSS and factors ...
André Luiz Carvalho Braule Pinto +9 more
doaj +1 more source
European Psychiatry, 2022 Introduction The delusional misidentification syndromes (DMS) are uncommon but fascinating neuropsychiatric disorders. One particularly intriguing form of DMS is called the mirror sign or mirror delusional misidentification (MDM).
S. Mouta +4 more
doaj +1 more source
European Psychiatry, 2023 Introduction The treatment with long-acting injectable antipsychotics (LAIAs) is more and more frequent and it shows advantages regarding adherence, effectiveness and tolerance.
J. R. P. Correia +4 more
doaj +1 more source
European Psychiatry, 2023 Introduction Suicide presents itself as a serious public health problem, with universal characteristics. Though world rates dropped between 2010 and 2016, they are still very high and in regions like the Americas there has been a raise in the same ...
J. A. Jaber Filho +4 more
doaj +1 more source
The impact of substance misuse in patients with first-episode psychosis: a retrospective study
European Psychiatry, 2023 Introduction Substance misuse increases the risk of developing psychosis in vulnerable people. However, patients with substance use disorders’ attributes and their effect on first-episode psychosis (FEP) are still unclear.
R. A. Moreira +4 more
doaj +1 more source
DELUSION OF PREGNANCY IN PATIENT WITH MAJOR NEUROCOGNITIVE DISORDER: A CASE REPORT
European Psychiatry, 2023 Introduction Delusion of pregnancy (DP) is a heterogeneous symptom that can emerge from different neuropsychiatric syndromes, including schizophrenia, bipolar disorders, but also major neurocognitive disorder (MND).
M. O. Pires +5 more
doaj +1 more source
Revista Portuguesa de Psiquiatria e Saúde Mental, 2021 .
Margarida Albuquerque +4 more
doaj +1 more source
Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment
European Psychiatry, 2023 Introduction Substance use disorders(SUDs) are a major health concern and current treatment interventions have proven only limited success. Despite increasing effectiveness, still about 50–60% relapse within 6–12 months after treatment [Cornelius et al.,
R. Sousa +9 more
doaj +1 more source